In this study, mice lacking the gp91 phox gene were used to address the role of NADPH oxidase in hyperhomocysteinemia-induced podocyte injury. It was found that a folate-free diet increased plasma homocysteine levels, but failed to increase O 2 •− production in the glomeruli from gp91 phox gene knockout (gp91 These results suggest that the functional integrity of NADPH oxidase is essential for hyperhomocysteinemiainduced podocyte injury and glomerulosclerosis.
Hyperhomocysteinemia (hHcys) has been known as a critical pathogenic factor both in the progression of end-stage renal disease (ESRD) and in the development of cardiovascular complications related to ESRD [1] [2] [3] . It has been reported that sustained hHcys may induce extracellular matrix accumulation and inhibit their degradation in the kidney, which ultimately leads to glomerulosclerosis [4] . Although many downstream signaling pathways are involved in hHcys-induced glomerulosclerosis, reactive oxygen species (ROS) are currently regarded as one of the most important mediators in the initiation of hHcys-induced kidney damage. Among ROS, superoxide (O 2
•−
) is a main source for other oxygen-centered radicals, such as H 2 O 2 and
• OH, which participate in lipid peroxidation and induce cellular membrane damage. Emerging evidence has highlighted the important role for the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-dependent system as a major source of O 2 •− in the kidney [5] . Recently, we and others have shown that NADPH oxidase activation and subsequent O 2 •− generation are important mechanisms in the development of hHcys-induced glomerulosclerosis [6, 7] . NADPH oxidase comprises the membrane-bound cytochrome b 558 (formed by gp91 phox and p22 phox subunits) and the cytosolic proteins p40 phox , p47 phox , p67 phox , and Rac1/2. The catalytic subunits of this enzyme are termed NOX proteins, which include NOX1, NOX2 (i.e., gp91 phox ), NOX3, NOX4, NOX5, DUOX1, and DUOX2 [8] . It has been reported that almost all components of the NADPH oxidase complex, including gp91
phox , p22 phox , p47 phox , p67 phox , and Rac1/2, are expressed in the kidney and that these NADPH oxidase components could be detected in renal fibroblasts, endothelial cells, vascular smooth muscle cells, mesangial cells, and tubular cells [9] . Among these, the catalytic subunit gp91 phox was shown to be essential for oxidative stress in the kidney. Previous studies using gp91 phox knockout mice have demonstrated that this enzyme plays important roles in the maintenance of renal vascular tone [10] , as well as in the regulation of renal hemodynamics and excretory function under a condition of nitric oxide deficiency [11] . Recently, several NADPH oxidase subunits, gp91 phox , p22 phox , p67 phox , and p47
phox , have been also demonstrated to be present in cultured podocytes [12] . Further studies showed that NADPH oxidase activation and subsequent O 2
•− production play a key role in high glucose-, angiotensin II-, and adriamycin-induced podocyte injury [13] [14] [15] . However, it remains unknown whether activation of NADPH oxidase is involved in hHcysinduced podocyte injury and related pathological changes.
Podocytes are terminally differentiated epithelial cells, which cover the outermost layer of glomerular filtration barrier and constitute the last and the most important barrier in preventing protein leakage from the plasma. Although podocyte injury has been considered as the most important early event in initiating glomerulosclerosis and thereby Free Radical Biology & Medicine 48 (2010) [1109] [1110] [1111] [1112] [1113] [1114] [1115] [1116] [1117] resulting in ESRD in various animal models and humans [16] [17] [18] , its involvement in hHcys-induced glomerular damage and sclerosis is still poorly understood. We hypothesized that homocysteine (Hcys) may directly cause podocyte injury through NADPH oxidasemediated O 2
•− production and that knockout or deletion of its functional subunit, gp91 phox , will protect podocytes from hHcysinduced injury. To test this hypothesis, we determined the possible injurious effect of hHcys on podocytes in mice lacking the gp91 phox gene and compared related pathological changes to their genetic background strain C57BL/6 mice. We further used cultured murine podocytes to examine the direct effects of gp91 phox gene deletion on
Hcys-induced functional changes in podocytes and explored the underlying mechanisms.
Materials and methods

Animal procedures
C57BL/6J wild-type (WT; 6 weeks of age, male) and gp91 phox knockout (KO) mice (6 weeks of age, male; The Jackson Laboratory, Bar Harbor, ME, USA) were used. All protocols were approved by the Institutional Animal Care and Use Committee of the Virginia Commonwealth University. Given the difficulty of the development of hyperhomocysteinemia in mice with both kidneys because of treatment that requires a long period of time, all gp91 phox KO mice and WT mice were subjected to a uninephrectomy, which helped accelerate the progression of hHcys-induced glomerular injury, as we reported previously [6] . This model was demonstrated to induce glomerular damage unrelated to the uninephrectomy and arterial blood pressure, but specific to hHcys. After a 1-week recovery period from the uninephrectomy, KO and WT mice were fed a normal diet or a folate-free (FF) diet (Dyets, Inc., Bethlehem, PA, USA) for 4 weeks to induce hHcys. One day before these mice were sacrificed, 24-h urine samples were collected using mouse metabolic cages. After blood samples were collected, the mice were sacrificed and renal tissues were harvested for biochemical and molecular analysis as well as morphological examinations.
High-performance liquid chromatography (HPLC) analysis
Plasma total Hcys levels were measured by HPLC as we described previously [19] . Briefly, blood samples were centrifuged at 1000g for 10 min at 4°C to isolate the plasma. One hundred microliters of plasma, or standard solution mixed with 10 μl of internal standard, thionglycolic acid (2.0 mmol/L) solution, was treated with 10 μl of 10% tri-n-butylphosphine solution in dimethylformamide at 4°C for 30 min. Then, 80 μl of ice-cold 10% trichloroacetic acid in 1 mmol/L EDTA was added and centrifuged to remove proteins in the sample. One hundred microliters of the supernatant was transferred into the mixture of 20 μl of 1.55 mol/L sodium hydroxide, 250 μl of 0.125 mol/L borate buffer (pH 9.5), and 100 μl of 1.0 mg/ml ABD-F solution. The resulting mixture was incubated at 60°C for 30 min to accomplish derivatization of plasma thiols. HPLC was performed with an HP 1100 series equipped with a binary pump, a vacuum degasser, a thermostated column compartment, and an autosampler (Agilent Technologies, Waldbronn, Germany). Separation was carried out at ambient temperature on an analytical column, Supelco LC-18-DB (1504.6-mm i.d., 5 m) with a Supelcosil LC-18 guard column (204.6-mm i.d., 5 m). Fluorescence intensities were measured with an excitation wavelength of 385 nm and emission wavelength of 515 nm by a Hewlett-Packard Model 1046A fluorescence spectrophotometer. The peak area of the chromatographs was quantified with a Hewlett-Packard 3392 integrator. The analytical column was eluted with 0.1 mol/L potassium dihydrogen phosphate buffer (pH 2.1) containing 6% acetonitrile (v/v) as the mobile phase with a flow rate of 2.0 ml/min.
Monitoring of arterial blood pressure in conscious mice
Mean arterial pressure (MAP) was measured 4 weeks after mice were treated with the normal or FF diet as we described previously [20] . In brief, mice were anesthetized by inhalation of isoflurane, and then a catheter connected to a telemetry transmitter was implanted into the carotid artery and the transmitter was placed subcutaneously. The arterial blood pressure signal from the transmitter was received by a remote receiver and then recorded by a computer program (Data Sciences International, St. Paul, MN, USA). Arterial blood pressure was continuously measured for 1 week after an equilibration period.
Electromagnetic spin resonance (ESR) analysis of O 2
•− production 
Measurement of creatinine clearance (Ccr)
Plasma and urinary creatinine concentrations (Pcr and Ucr) were measured as described before [23] . In brief, 24-h urine samples were collected using metabolic cages. Blood samples for serum creatinine were collected at the time the mice were sacrificed. Serum and urinary creatinine concentrations were measured by a QuantiChrom creatinine assay kit (BioAssay Systems, Hayward, CA, USA). Ccr was calculated using the following formula: Ccr (μl/min) = (Ucr/Pcr) × urine volume (μl/min).
Urinary total protein and albumin excretion measurement
The 24-h urine samples were collected using metabolic cages and subjected to total protein and albumin excretion measurement, respectively. Total protein content in the urine was detected by the Bradford method using a UV spectrometer. Urine albumin was detected using a commercially available mouse albumin ELISA kit (Bethyl Laboratories, Montgomery, TX, USA).
Morphological examination
For observation of renal morphology using light microscopy, renal tissues were fixed with 10% formalin solution, paraffin-embedded, and stained with periodic acid-Schiff (PAS). Glomerular sclerosis was assessed by a standard semiquantitative analysis and expressed as glomerular damage index (GDI) [24] . Fifty glomeruli per slide were counted and graded as 0, 1, 2, 3, or 4, according to 0, b25, 25-50, 51-75, or N75% sclerotic changes across a longitudinal kidney section, respectively. The GDI for each mouse was calculated by the formula ((N 1 × 1) + (N 2 × 2) + (N 3 × 3) + (N 4 × 4))/n, where N 1 , N 2 , N 3 , and N 4 represent the numbers of glomeruli exhibiting grades 1, 2, 3, and 4, respectively, and n is the total number of glomeruli graded.
For transmission electron microscopic (TEM) observation of ultrastructural changes in podocytes, the kidneys were perfused with a fixative containing 3% glutaraldehyde and 4% paraformaldehyde in 0.1 M phosphate buffer. The kidneys were sliced longitudinally and cortical strips were cut into 1-mm 3 tissue blocks, which were further fixed with 3% glutaraldehyde for 12 h. After dehydration with ethanol, the samples were embedded in Durcupan resin for ultrathin sectioning and TEM examinations by the VCU electron microscopy core facility.
Real-time reverse transcription polymerase chain reaction (RT-PCR)
Total RNA from isolated mouse glomeruli or cultured podocytes was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the protocol as described by the manufacturer. RNA samples were quantified by measurement of optic absorbance at 260 and 280 nm in a spectrophotometer. The concentrations of RNA were calculated according to A 260 . Aliquots of total RNA (1 μg) from each sample were reverse-transcribed into cDNA according to the instructions of the first-strand cDNA synthesis kit manufacturer (Bio-Rad, Hercules, CA, USA). Equal amounts of the reverse-transcriptional products were subjected to PCR amplification using SYBR green as the fluorescence indicator on a Bio-Rad iCycler system (Bio-Rad). The mRNA levels of target genes were normalized to the β-actin mRNA levels. The primers used in this study were synthesized by Operon (Huntsville, AL, USA) and the sequences were gp91 phox , sense TGGCA CATCGATCCCTCACTGAAA, antisense GGTCACTGCATCTAAGGCAACCT; vascular endothelial growth factor-A (VEGF-A), sense CAATGAT-GAAGCCCTGGAG, antisense TCTCCTATGTGCTGGCTTTG; and β-actin, sense TCGCTGCGCTGGTCGTC, antisense GGCCTCGTCACCCACATAGGA.
Immunofluorescent staining and immunohistochemistry
Indirect immunofluorescent staining was performed using frozen slides of mouse kidneys. After fixation with acetone, the slides were incubated with rabbit anti-nephrin 1:100 (Abcam, Cambridge, MA, USA), rabbit anti-podocin 1:200 (Sigma), or rabbit anti-desmin 1:100 (BD Biosciences, San Jose, CA, USA), overnight, at 4°C. Then, the slides were washed and incubated with corresponding FITC-labeled secondary antibodies. Finally, the slides were washed, mounted, and subjected to fluorescence microscopy examination. The images were captured with a Spot CCD camera (Diagnostic Instruments, Sterling Heights, MI, USA). All exposure settings were kept constant for each group of kidneys.
Because WT1 (Wilms' tumor suppressor gene) is exclusively expressed by podocytes and not by other cell types in the glomeruli, podocyte numbers were counted in mouse glomeruli using immunohistochemistry staining for WT1 as reported previously [25] . Briefly, kidney sections from paraffin-embedded tissues were prepared at 4-μm thickness and stained by an antibody to WT1 (1:50 dilution; Abcam) using a routine immunohistochemistry procedure. After staining, 50 consecutive glomerular cross sections per mouse were randomly chosen and the positively stained podocytes were counted by an observer who was blinded to the sample identity. Six mice were analyzed for each group. The number of podocytes per glomerulus was calculated from podocyte density multiplied by the glomerular volume as described before [26] .
Cell culture
A conditionally immortalized mouse podocyte cell line, kindly provided by Dr. P.E. Klotman (Division of Nephrology, Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA), was cultured on collagen I-coated flasks or plates in RPMI 1640 medium supplemented with recombinant mouse interferon-γ at 33°C. After differentiating at 37°C for 10-14 days without interferon-γ, the podocytes were used for the proposed experiments. In this study, the preparation of L-Hcys (a pathogenic form of Hcys) and the concentration and incubation time of L-Hcys treatment were chosen based on our previous studies in mesangial cells [27] and our preliminary experiments on podocytes.
Gp91
phox siRNA transfection Gp91 phox siRNA, purchased from Qiagen (Valencia, CA, USA), was confirmed to be effective in silencing the gp91 phox gene in various cells by the company. The scrambled RNA (sRNA; Qiagen) was confirmed as nonsilencing double-stranded RNA and used as the control in this study. Podocytes were serum starved for 12 h and then transfected with gp91 phox siRNA or sRNA using the siLentFect lipid reagent (BioRad). After 18 h of incubation at 37°C, the medium was changed and LHcys (80 μmol/L) added into the medium for the indicated times.
ELISA for VEGF-A secretion in podocytes
After being transfected with gp91 phox siRNA or sRNA, or pretreated with diphenyleneiodonium (DPI; a NADPH oxidase inhibitor), podocytes were incubated with L-Hcys (80 μmol/L) for 24 h. A relatively specific podocyte injury compound, puromycin aminonucleoside (PAN; 100 μg/ml), was used to treat cells for 24 h to serve as a positive control. The supernatant was collected for ELISA of VEGF-A using a commercially available kit (R&D Systems, Minneapolis, MN, USA).
Statistical analysis
All of the values are expressed as means ± SEM. Significant differences among multiple groups were examined using ANOVA followed by a Student-Newman-Keuls test. The χ 2 test was used to access the significance of ratio and percentage data. P b 0.05 was considered statistically significant.
Results
Reduction of hHcys-induced O 2
•− production in gp91 phox KO mice
As shown by HPLC analysis, plasma Hcys levels were similar in WT and gp91
phox KO mice on the normal diet. FF diet treatment significantly increased plasma Hcys levels in both WT and gp91 phox KO mice (Fig. 1A) . ESR analysis showed that glomerular O 2
•− production was lower in KO mice than in WT mice on the normal diet. On the FF diet, glomerular O 2 •− production increased by 2.4-fold in WT mice. However, FF diet-induced O 2 •− production was much less in KO mice compared with WT mice (Figs. 1B and 1C) .
Alleviation of glomerular injury in gp91 phox KO mice on the FF diet
In parallel to the elevation in plasma Hcys levels, the 24-h urinary total protein and albumin excretion was significantly increased in WT mice on the FF diet. In gp91 phox KO mice, however, a similar level of plasma Hcys caused much less urinary total protein and albumin excretion ( Figs. 2A and 2B) . By PAS staining, we observed a typical pathological change in glomerular sclerotic damage in WT mice on the FF diet (Fig. 3A) . The average GDI was substantially higher in WT mice on the FF diet, but much less in gp91 phox KO mice on the same diet (P b 0.05, Fig. 3B ). To evaluate the glomerular filtration rate (GFR) of these mice, Ccr was measured. It was found that FF diet treatment induced a decline in Ccr in WT mice, whereas the Ccr was mostly preserved in gp91 phox KO mice on the same diet (Fig. 4A) . To explore whether these renal functional and pathological changes were associated with elevation of arterial blood pressure, MAP was measured in conscious mice using telemetry. FF diet treatment had no effect on MAP in either WT or KO mice (Fig. 4B) .
Expression of nephrin, podocin, and desmin in gp91 phox KO and WT mice
Next we determined whether the protective effect of gp91 phox gene knockout is associated with the protection of podocytes from hHcys-induced injury. Real-time RT-PCR demonstrated that the mRNA levels of two important slit diaphragm molecules, nephrin and podocin, were significantly decreased by the FF diet in WT mice, which decrease was much less in KO mice on the same diet. However, the expression of desmin, a podocyte injury marker, was significantly increased in WT mice on the FF diet compared with gp91 phox KO mice (P b 0.05, Fig. 5A ). As shown by indirect immunofluorescent staining in Fig. 5B , nephrin and podocin staining was seen as a fine linear-like pattern along the glomerular capillary loop in mice on a normal diet. The expression of both nephrin and podocin showed a dramatic decrease in WT mice on the FF diet, which was less obvious in the gp91 phox KO mice on the same diet. In contrast, the expression of desmin was less increased in gp91 phox KO mice on the FF diet compared with WT mice.
Attenuation of hHcys-induced foot process effacement and podocyte loss in gp91 phox KO mice
To observe ultrastructural changes in podocytes, TEM was conducted. Compared with the distinct brush-like structures of podocyte foot processes seen in mice on the normal diet, evident foot process effacement was observed in WT mice 4 weeks after FF diet treatment. In contrast, podocytes of gp91 phox KO mice on the FF diet had relatively normal ultrastructures (Fig. 6A ). To investigate whether gp91 phox gene knockout helps to maintain podocyte numbers, we counted the number of podocytes per glomerular cross section in WT and KO mice. Podocytes were identified by staining with an antibody against the podocyte-specific marker WT1. There were similar numbers of WT1-stained podocytes in WT and KO mice fed a normal diet. FF diet treatment induced a significant decrease in podocyte numbers in WT mice, but not in KO mice (Figs. 6B and 6C).
Blockade of Hcys-induced O 2
•− production by gp91 phox gene silencing in
cultured podocytes
Although we have demonstrated in whole-animal experiments that the glomeruli of gp91 phox KO mice were protected from hHcysinduced renal injury, it has yet to be determined whether such protective action is due to the direct protection of podocytes. To address this issue and to explore potential underlying mechanisms, we used in vitro cultured podocytes to examine the role of gp91 phoxcontaining NADPH oxidase in Hcys-induced podocyte injury. Realtime RT-PCR showed that L-Hcys stimulated the expression of gp91 phox at both the mRNA and the protein level (P b 0.05, Fig. 7A ).
This increased gp91 phox expression was accompanied by an elevated NADPH oxidase-dependent O 2 •− production (Fig. 7B) . When podocytes were transfected with gp91 phox siRNA, Hcys-induced O 2 •− production was significantly inhibited, which was comparable to the inhibition by DPI, a NADPH oxidase inhibitor (P b 0.05, Fig. 7C ).
Blockade of Hcys-induced decrease in VEGF-A secretion in podocytes by gp91 phox siRNA gene silencing
As a functional parameter of podocytes, VEGF-A production was detected in podocytes under various conditions. Fig. 8A shows that the mRNA expression of VEGF-A was decreased by L-Hcys in a concentration-dependent manner. As shown in Figs. 8B and 8C, VEGF-A production and secretion were dramatically reduced by the treatment with L-Hcys (P b 0.05), which was similar to the designated positive control, PAN. When gp91 phox siRNA was transfected to inhibit O 2
•− production via NADPH oxidase, Hcys-induced decrease in VEGF-A secretion was significantly restored (P b 0.05). Similarly, inhibition of NADPH oxidase activity using DPI also recovered VEGF secretion in podocytes.
Discussion
The goals of this study were to determine whether podocytes are a direct target of hHcys and to investigate the role of NADPH oxidasedependent O 2
•− production in hHcys-induced podocyte injury. Using an FF diet-induced hHcys animal model in gp91 phox gene-deficient mice and in vitro cultured podocytes, we clearly demonstrated that hHcys directly induces podocyte injury and depletion through gp91 phox -containing NADPH oxidase activation and O 2 •− production.
There is considerable evidence supporting the critical role of ROS, particularly O 2
•−
, in the pathogenesis of kidney diseases, such as diabetic nephropathy [28] and hypertension-related nephropathy [29] . Among various enzymes involved in the generation of ROS, NADPH oxidase is regarded as the main source of O 2
•− production. Gp91 phox , also known as NOX2, is the catalytic subunit of NADPH oxidase. Although there are some reports indicating that NOX1 and NOX4 are also expressed in the kidney [30, 31] , data from our laboratory and other groups have strongly suggested that the gp91 phox -containing NADPH oxidase system is more critical in mediating O 2 •− production in the kidney [4, 10, 11, 32] . Therefore, we used gp91 phox -deficient mice to explore the role of NADPH oxidase- •− production in many organs, such as the heart, lungs, and brain, which protects these mice from various pathophysiological conditions such as cardiac hypertrophy [8] , hypoxic pulmonary hypertension [33] , and surgically induced brain injury [34] . In accordance with lowered O 2 •− production in gp91 phox KO mice on the FF diet, urine albumin excretion in these mice was significantly decreased compared with WT mice on the same diet, suggesting that ROS-associated renal injury during hHcys is alleviated in these KO mice. Pathological studies using PAS staining showed that there was a significant improvement of hHcys-induced glomerulosclerosis in these KO mice compared with WT mice. Consistent with these pathological changes, GFR was also preserved in these KO mice on the FF diet. In addition, a 4-week FF diet treatment had no influence on arterial blood pressure of WT and gp91 phox KO mice, indicating that the preservation of podocyte function and structure in these KO mice is not associated with any change in blood pressure. All these results support the view that gp91 phox -containing NADPH oxidase mediates O 2 •− production in the glomeruli and thereby plays a critical role in hHcys-induced renal injury. One of the most important findings of this study is that gp91 phox gene deficiency may protect podocytes from hHcys-induced injury. Podocytes serve as the final defense mechanism against urinary protein loss in the normal glomerulus [35] . Damage to podocytes and their slit diaphragm is intimately associated with proteinuria and glomerulosclerosis in many kidney diseases, such as focal segmental glomerulosclerosis, diabetic nephropathy, and hypertension-associated nephropathy [36, 37] . In recent studies, we have reported that foot process effacement was presented in a methionine-induced animal model of hHcys [23] , but the mechanism has not yet been explored. Here, we demonstrated for the first time that hHcys could induce podocyte injury through NADPH oxidase-mediated O 2 •− production, which was supported by analysis of the levels of some slit diaphragm molecules such as nephrin and podocin and by measuring the podocyte damage marker desmin. As is well known, nephrin and podocin are two important components of the slit diaphragm complex, which play an essential role in maintaining the normal structure of the glomerular filtration barrier. Mutation or downregulation of these proteins is associated with a defective filtration barrier causing proteinuria [38] . In addition, nephrin affords important signaling cascades through its interaction with podocin and CD2-associated protein (CD2AP) for maintaining the normal growth of podocytes and preventing their apoptosis [38] . So, the decreased expression of nephrin is not only an indicator of slit diaphragm damage, but also a sign of a disturbed intracellular signaling pathway that is essential for podocyte survival. The results from this study show that hHcys induced a dramatic decrease in nephrin and podocin expression in WT mice, but not in gp91 phox KO mice. It seems that hHcys may disrupt the normal structure of the slit diaphragm complex and the related intracellular signaling events through NADPH oxidase-mediated O 2 •− production. This Hcysinduced podocyte injury and its attenuation in gp91 phox KO mice were also demonstrated by the increase in desmin expression.
Desmin is an intermediate filament protein, which has long been suggested as a specific and sensitive podocyte injury indicator [7] , and its expression is often up-regulated in various glomerular diseases in which podocyte damage is involved [18, 39] . In this study, we showed that hHcys induced by the FF diet significantly increased desmin expression in the glomeruli of WT mice, but much less in gp91 phox gene KO mice, further suggesting that podocyte injury is significantly attenuated because of reduced O 2 •− generation in the kidney.
Among various morphologic characteristics, foot process effacement and consequent podocyte depletion are strong predictors for the progression of glomerulosclerosis. It has been proposed that the loss of b20% of podocytes triggers mesangial expansion, loss of 20-40% produces small patches of podocyte depletion and synechia formation, and N40% podocyte depletion produces the full picture of focal segmental glomerulosclerosis with segmental and eventually global sclerosis [40] . Although these observations identify podocyte depletion as one of the earliest cellular features of many types of kidney diseases, the mechanisms underlying the loss of podocytes remain poorly understood. Recently, it has been demonstrated ROS activation is a key mechanism leading to podocyte loss in animal models of diabetic nephropathy [13] and PAN-induced nephropathy [41] . In this study, the TEM data showed that FF diet treatment caused podocyte foot process effacement in WT mice, and such damage was dramatically attenuated in gp91 phox KO mice on the same diet. The fact that gp91 phox gene deletion provided protection from podocyte foot process effacement indicates that this podocyte injury is a direct action of hHcys on podocytes and it is through NADPH oxidasemediated ROS toxicity. Using WT1 staining to calculate podocyte numbers and evaluate podocyte loss in the glomeruli, we found that hHcys significantly decreased podocyte numbers in the glomeruli of WT mice, indicating a podocyte loss under such pathological conditions. Interestingly, gp91 phox gene deletion prevented such podocyte loss induced by hHcys. These results suggest that the activation of NADPH oxidase and subsequent O 2 •− production is an important mechanism in mediating Hcys-induced podocyte injury and death. In harmony with our results, Liu et al. recently provided evidence showing that up-regulation of NADPH oxidase activity plays a pivotal role in mediating proximal tubular cell apoptosis in transgenic mice overexpressing angiotensinogen [42] . It should be noted that some previous studies reported the effects of hHcys in inducing renal cell proliferation through the activation of NADPH oxidase in other cell types such as mesangial cells [27] . It seems that the action of NADPH oxidase in causing cell proliferation or death may be cell-type specific. Although the function of NADPH oxidase-derived ROS in mediating renal cell proliferation and death seems to be paradoxical, these actions may eventually converge at the functional level, in that both processes may be detrimental (for example, proliferation of mesangial cells and depletion of podocytes) to normal kidney functions [43] . To address whether this protective effect of gp91 phox gene deletion is directly associated with counteracting Hcys-induced injury to podocytes, we used cultured murine podocytes to examine the direct effects of gp91 phox gene silencing on Hcys-induced functional changes. mediates high-glucose-induced podocyte injury using the same cell line as we used [13] . There is also another study indicating that NADPH oxidase-mediated O 2 •− generation serves as the main mediator of PAN-induced podocyte damage [44] . It seems that NADPH oxidase-mediated O 2 •− production is an important detrimental factor in podocyte injury, which may initiate and promote glomerulosclerosis.
To further investigate the functional abnormality of Hcysinduced podocyte injury via NADPH oxidase activation, we examined the production of VEGF-A in cultured podocytes. In the kidney, VEGF-A is mainly derived from podocytes and regulates the cytoskeletal organization and migration of glomerular endothelial cells, facilitating the formation of a new vascular lumen [45] . A recent report has demonstrated that podocytes have a functional autocrine VEGF-A system, which is regulated by differentiation and ligand availability [46] . The function of VEGF-A in podocytes includes promoting cell survival through VEGFR2, inducing podocin up-regulation, and increasing nephrin/CD2AP interaction [46] . VEGF-A may also serve as a crucial growth factor in maintaining the normal function of podocytes by preventing their apoptosis through the interaction with nephrin and activation of the AKT signaling pathway [47] . Podocyte-derived VEGF-A is decreased in sclerotic glomeruli [48] , whereas treatment with exogenous VEGF-A decreases renal sclerotic injuries and restores glomerular capillaries [49] . In this study, we found that Hcys treatment significantly decreased the production of VEGF-A in podocytes, which was restored by silencing of the gp91 phox gene or by inhibition of NADPH oxidase activity. It seems that elevated O 2 •− production induced by Hcys damages the normal function of podocytes to secrete this important growth and permeability factor in the glomeruli. Given the important role of VEGF in maintaining the normal function of podocytes and preventing their apoptosis, it is plausible that decreased nephrin expression, reduced VEGF excretion, and subsequent disturbed VEGF-nephrin interaction induced by hHcys may contribute importantly to Hcys-induced podocyte depletion. In summary, this is the first report showing that Hcys may directly cause podocyte injury and depletion, which are important events leading to glomerulosclerosis associated with hHcys. Using a gp91 phox gene KO mouse model, we found that all hHcys-induced structural and functional changes reflecting podocyte injury were alleviated, such as proteinuria, reduced expression of podocin and nephrin, increased desmin level, foot process effacement, and podocyte loss. In cultured murine podocytes, we further demonstrated that silencing of the gp91 phox gene inhibited O 2 •− production induced by Hcys and recovered Hcys-induced decrease in secretion of VEGF-A. Collectively, these results demonstrate that a direct injurious effect of hHcys on podocytes is mainly mediated by a mechanism that involves generation of O 2 •− by the gp91 phox -containing NADPH oxidase, which may represent a specific early mechanism mediating hHcysinduced glomerulosclerosis.
